sb 203580 has been researched along with Koch's Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Juffermans, NP; Peppelenbosch, MP; Schultz, MJ; ten Hove, T; van den Blink, B; van der Poll, T; van Deventer, SJ | 1 |
1 other study(ies) available for sb 203580 and Koch's Disease
Article | Year |
---|---|
p38 mitogen-activated protein kinase inhibition increases cytokine release by macrophages in vitro and during infection in vivo.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Cytokines; Disease Models, Animal; Endotoxemia; Enzyme Inhibitors; Female; Humans; Imidazoles; Injections, Intraperitoneal; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Pneumonia, Pneumococcal; Pyridines; Tuberculosis; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Up-Regulation | 2001 |